Fig. 3From: Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease riskPlot of the Monte-Carlo p-value cutoffs for each antibody prevalence between 0 and 1 with step size 0.01. For high prevalences (> 0.4) and any prevalences with too few instances advancing to phase 2, the mean of the remaining cutoffs was usedBack to article page